

A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction.

The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.

Want to know more?